InnerSpace’s line of Harmony storage and procedure carts are available with standard drawer configurations or can be customized using the “Build-A-Cart” option (using 3-inch, 6-inch and 9-inch drawers or similar-sized trays and baskets).
A locking drawer can be used in conjunction with trays and baskets for medications and syringes. Heavy-duty plate casters, central key-lock and a pullout writing surface are standard. Optional electronic keyless entry is also available, which incorporates an auto re-lock feature, low battery indicator and manual key override.

Fukuda Denshi has partnered with Criticare Systems Inc. to distribute the Poet IQ 8500A with the DS-7300 patient monitor. The addition of the IQ 8500A now provides the capability to move the DS-7300 patient monitor into the OR environment. The DS-7300/IQ 8500A combination delivers high performance monitoring of CO2 and O2 along with five halogenated gas agents and an OR-specific software package to meet the needs of the demanding OR environment.

The TRUMPF iLED uses 184 white and color LEDs to provide 160,000 Lux of low heat, virtually shadow-free illumination. One of its most unique features is that it gives the surgical team — for the first time ever — the ability to change color temperature.
Bathed in warm, nonglare light (about 3,500 Kelvin), skin and light tissue parts reflect less and the contrast remains intact. Colder light colors (up to 5,000 Kelvin), however, were preferred in tests for deeper lying body areas and for longer surgeries.

Medafor Inc. received FDA clearance for its Arista AH absorbable hemostasis powder in September 2006, and the hemostat has compiled a record of success in more than 100,000 surgeries worldwide, raising expectations for its entrance to U.S. medical markets.
Currently, Arista AH is indicated for most surgeries including cardiac, thoracic, orthopedic, spinal and general applications. It is the only new generation surgical hemostat that is instantly ready to use, requiring no mixing, no addition of patient blood or other components and no special handling or storage conditions.

VIE Healthcare Inc. announces its proprietary equipment pre-lease review, lease audit and lease management service dedicated to healthcare organizations. VIE's Equipment Lease Auditing and Management Services reportedly uncovers errors and overpayments in current leases, provides an essential pre-lease audit of pricing, terms and conditions before signing the lease agreement, assists healthcare organizations in competitive lease bids, and manages leases throughout the term in order to avoid unnecessary costs and overpayments.

LumitexMD has introduced a new version of its LightMat Surgical Illuminator, featuring an integral adhesive that makes it easier to handle and use, and provides a thinner profile for ORs and ASCs.
The new easy-to-use Ultra-Thin LightMat comes with Ultra-Brite technology. It also includes extra wraparound adhesives, helpful in particularly rugged (e.g., hip) or oily cases (e.g., breast).

ClearPath, from North American Scientific Inc. (NASI), is a multi-catheter high dose rate breast brachytherapy device. Designed to conform to the resection cavity following lumpectomy, allowing for more conformal radiation dose distribution during treatment, and to accommodate either high-dose or low-dose rate treatments, ClearPath is placed through a single incision. NASI received 510(k) marketing clearance from the FDA for a low-dose rate, or continuous release treatment using the company’s Prospera brachytherapy seeds in April 2006.

The time lag between planning and seed implantation can degrade the effectiveness of treatments as tumor targets size and location change.

The QuickLink Delivery System brings real-time linked brachytherapy to reality. Build linked seed trains with variable spacing easily and effectively in a short time, in the OR, in real time.
The QuickLink Delivery System delivers the benefits of a connected implant with the advantages of real-time planning: simple and intuitive for efficient loading; creates custom needle loads with variable spacing; requires no handling of individual seeds; allows easy verification of seed and link configurations; for use only with SourceLink connectors.

Bard

Xoft Inc.’s Axxent Electronic Brachytherapy System is designated for the treatment of breast cancer. Electronic Brachytherapy is a proprietary technology platform designed to deliver localized, nonradioactive, isotope-free radiation treatment in a minimally-shielded clinical setting. As Xoft’s first treatment system, Axxent is designed for use in Accelerated Partial Breast Irradiation for the treatment of early stage breast cancer.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now